LOS ANGELES, Oct. 3, 2025 — Wave Function Ventures is excited to announce the final close of its $15M Fund I. Wave Function was created to partner with deep tech founders building hardware solutions to the world’s most important problems.
Wave Function Ventures was started by industry veteran and solo GP Jamie Gull. Jamie has done it all; he’s built hardware, founded companies, raised venture capital, won contracts with the DoD, and ultimately exited companies. He is a former SpaceX engineer who played a key role on Falcon 9 reentry, designed and built aircraft at Scaled Composites, and cofounded and sold his own deep tech company, Talyn Air, a company that successfully went through Y Combinator. With this experience he is uniquely positioned to be the right thought partner for early stage founders at the most critical stage of their company building.
Wave Function invests across critical ‘deep tech’ sectors such as aerospace, defense, energy, robotics, and infrastructure and partners with founders at the earliest stages. In some cases, Wave Function will invest pre-incorporation, where Jamie can help founders shape rough ideas into compelling product plans and visions. Fund I has already made nine investments spanning those sectors, and the portfolio has shown strong traction, including multiple follow-on investments from top-tier firms.
“There’s never been a better time to build in hardware and create the next generation of huge companies with enduring legacies”, says Jamie, “and the best part is building something that truly matters.”
Fund I LP’s include founders, engineers, HNW individuals, as well as institutional support from Fund of Funds and large Family Offices.
With Fund I closed, it’s time to get back to building and backing and supporting incredible founders tackling the world’s most pressing problems, all while scaling Wave Function Ventures into a leading firm investing in hardware for the future.
Wave Function Ventures is excited to announce the final close of its $15M Fund I. Wave Function was created to partner with deep tech founders building hardware solutions to the world’s most important problems.
Top backend for AI-driven development will use new funding to serve the most data-intensive enterprises
SAN FRANCISCO, Oct. 3, 2025 — Supabase, the Postgres development platform, has raised $100 million in Series E funding at a $5 billion valuation. The round was led by Accel and Peak XV with participation from Figma Ventures and other returning investors, underscoring strong confidence in the company’s growth. The round comes just four months after their Series D, bringing their total funding to over $500 million.
As part of the Series E funding, Supabase intends to reserve an allocation for its community members to co-invest alongside institutional partners. This initiative reflects the founders’ commitment to community, and will provide an opportunity for open source advocates to participate directly in the company’s growth.
“Our community is what makes Supabase special, and it’s a priority to give them the opportunity to co-invest in what we’re building,” said Paul Copplestone, co-founder and CEO of Supabase. “With the new capital we’ll continue serving our community of over 4 million developers while building open source tools to scale Postgres.”
This round marks what has been a banner year for Supabase, emerging as the preferred backend for AI-driven development. Platforms like Lovable and Bolt run on Supabase, alongside more than 100,000 customers; from over 50% of the latest Y Combinator batch, to enterprises such as PwC, McDonald’s, and Github Next.
“Supabase is scaling with clarity and conviction while redefining what it means to build applications with AI,” said Arun Mathew, partner at Accel. “With millions of developers, enterprise validation, and a team of entrepreneurial builders, Supabase is emerging as the defining database for the next generation of software.”
Peak XV’s Shailendra Singh continued, “We’re excited to co-lead Supabase’s Series E alongside Accel. Supabase started with managed Postgres but is now evolving into a platform company. Their incredible developer-first mindset has made them a critical enabler for hundreds of thousands of new AI startups globally, powering the AI supercycle for millions of developers. This is our third consecutive investment since co-leading their Series C a year ago, reflecting our deep conviction in Paul, Ant, Rory and their leadership team. We’re thrilled to continue this enduring partnership as Supabase scales to its next phase of growth.”
Over 4 million developers choose to use Supabase, often alongside Cursor and Claude Code, because it allows them to quickly spin up a backend that instantly updates itself with commands from AI.
The new capital will accelerate Supabase’s work on “Multigres”, an enterprise-scale version of its platform designed for large, data-intensive applications. To lead the effort, Supabase has hired Sugu Sougoumarane, the co-creator of Vitess. Sougoumarane is among a growing list of industry-leading database and open source founders working at Supabase; including Postgres core contributors, the NGINX co-founder, and the founders of various Y Combinator companies.
“We invested in Supabase at the seed because developers shouldn’t have to choose between speed and scale. Today, the ability to build in a weekend and scale to millions is not just possible, it’s routine with Supabase,” said Caryn Marooney, General Partner at Coatue. “This new financing aims to accelerate Supabase’s efforts to become the backend for everyone, from startups to some of the most demanding, data-intensive enterprise workloads.”
About Supabase Supabase is the Postgres development platform. It has emerged as the preferred backend for AI-driven development. Over 4 million developers choose to use Supabase, often alongside Cursor and Claude Code, because it allows them to quickly spin up a backend that instantly updates itself with commands from AI. This simplicity in workflow has driven Bolt, Figma, and Lovable to choose Supabase as the default backend for all projects on their platforms.
MADRID, Oct. 2, 2025 — Incus Capital (Incus), the Madrid-based real assets private credit specialist, announces the first close of its European Credit Fund V (Fund V), securing 50% of the fund´s target size in closed and committed capital. The fund is targeting €800 million, with a hard cap of €1 billion.
Fund V received strong support from a diversified investor base, including a significant number of repeat commitments from prominent institutions in North America and Europe. The fund also attracted new commitments from leading insurance companies, pension funds, global consultants and family offices, reinforcing continued interest in Incus’ differentiated investment strategy.
Martin Pommier, Partner of Incus, said: “We are grateful for the continued trust from our long-standing investors and are delighted to welcome new, high-quality institutions to our latest flagship fund series. We are pleased with this significant first close for Fund V. The strong investor demand demonstrates the confidence investors place in our record of delivering consistent returns across our funds.”
Investors view Fund V´s asset-based lending (ABL) approach as having the potential to generate attractive returns with strong downside protection, complementing more traditional direct lending portfolios. The ABL market is significantly larger than the underlying direct lending market. The direct lending market is expected to reach €1.5 trillion in 2025, while the ABL market is currently estimated at more than €6 trillion globally1. Despite this, the number of private capital firms focusing on ABL remains quite small in comparison to direct lending.
Andrew Newton, Founder and Managing Partner of Incus, said: “The European landscape continues to be poorly served by capital providers and the opportunity for ABL funds today is overwhelming. The appetite for Incus’ customized credit strategy is stronger than ever, reflecting the broad acceptance of alternative financing for European mid-market companies. Our newly launched Fund V program allows us to invest across a diverse sector of real asset classes.”
Fund V is positioned to capitalize on a robust pipeline of attractive opportunities across infrastructure, real estate, and alternative assets, supporting companies and projects with flexible solutions while targeting strong risk-adjusted returns.
Incus recently closed a number of investments in the European mid-market, including:
€55 million financing to a leading self-storage platform with 10 locations and 50,000 square meters in Portugal
€45 million senior loan to sponsor backed 5-star hotel & high-end residences in Courchevel 1850, France
€90 million facility to a leader in water management in the Valencia region of Spain
€60 million financing for a market leader in campsite operations across Iberia
About Incus Capital Founded in 2012, Incus Capital is a real assets investment firm with offices in Madrid, Lisbon, Milan, Paris, Frankfurt and Luxembourg. Incus provides flexible capital solutions to mid-market companies in Europe with a focus on infrastructure, real estate and alternative assets. The firm’s investment strategy includes a strong focus on downside protection with target investment sizes between €25 million to €60 million. Incus Capital acts as the investment advisor to funds with €3 billion in assets under management. For further information, visit www.incuscapital.com or watch Incus Capital 2025 AGM
The Lisk EMpower Fund targets post-incubation Web3 startups in Africa, Latin America, and Southeast Asia, bridging the capital gap and unlocking outsized returns in regions where Web3 adoption is already mainstream.
ZUG, Switzerland, Oct. 2, 2025 — Lisk, the growth platform designed for Web3 founders in high-growth markets, today announced the launch of the Lisk EMpower Fund, a $15 million venture initiative aimed at backing Web3 startups solving real-world problems in Africa, Latin America, and Southeast Asia. In addition to the launch of the Lisk EMpower fund, Lisk is excited to announce four early recipients: Lov.cash, a South African digital supply chain platform, Afrikabal, an African Agritech platform, IDRX, an Indonesian stablecoin, and SigraFi, who finances small gold producers and issues gold-backed onchain loan notes.
Lisk Launches the EMpower Fund
While developed markets often see competitive and dense VC activity and higher valuations, the Lisk EMpower Fund is hyper-focused on emerging markets where adoption is organic, purpose-driven, and transformative. To date, VCs are overlooking a $5.2 trillion opportunity in emerging markets, where small-to-medium-sized businesses remain underfunded.
“Global VCs have become obsessed with speculation. In high-growth markets, the opposite is true. Founders are solving real problems with real utility and that is where the next unicorns will come from,” said Gideon Greaves, Head of Investments at Lisk.
High-growth markets offer significant growth opportunities, leveraging emerging technology to develop innovative solutions that solve local challenges that otherwise could not be solved by traditional technology. Many founders bootstrap to Series-A level traction without ever raising institutional seed capital. Yet, a knowledge gap remains in the opportunities to invest in these regions.
Emerging markets have consistently outperformed public benchmarks, delivering 9-11% annualized venture returns over the past 10-15 years, according to Cambridge Associates. Lisk believes this marks the start of a generational bull run in emerging markets, driven by unprecedented innovation and the rapid adoption of transformative technologies. In contrast, U.S. seed-stage venture has become oversaturated, with record-high early-stage valuations and near-zero three-year returns. This creates an opportunity to back high-growth founders in Africa, Latin America, and Southeast Asia at fair valuations, while generating uncorrelated, venture-scale returns.
The disconnect is Lisk’s opportunity. The Lisk EMpower Fund addresses a critical gap that most VCs continue to miss. By backing founders at the earliest stages, the Lisk EMpower Fund delivers more than capital, it offers hands-on advisory, Web3 experience, and resources, becoming long-term partners with the founders at the intersection of local impact and global growth.
“Emerging markets are no longer the future of Web3, they are the present,” said Dominic Schwenter, COO at Lisk. “The Lisk EMpower Fund is designed to bridge the capital gap for world-class founders who are building global companies from these ecosystems.”
The Lisk EMpower Fund model integrates incubation, assessment, and growth capital through a scalable, end-to-end pipeline designed to accelerate high-potential ventures.
Web3-Native: Dedicated capital for infrastructure and applications solving real-problems in payments, remittances, identity, and supply chain.
Emerging Markets: Targeting regions that are ripe for organic adoption and have the potential to scale globally.
Hands-on Advisory: Beyond capital, Lisk operates as a boutique investment bank for startups, supporting founders in refining their narratives, structuring for international fundraising, and securing proper Series A and B rounds.
Tokenized Fund Structure: The Lisk EMpower Fund utilizes tokenization to streamline LP subscriptions, provide secondary market liquidity, and open access to retail LPs, who are traditionally excluded from venture funds.
By investing in the essential digital infrastructure of emerging economies, Lisk generates venture-scale returns uncorrelated with saturated Western markets. Its structured investment model is designed to de-risk early-stage ventures while providing hands-on advisory support to prepare them for global institutional investment.
Through strategic partnerships with leading local incubators, Lisk gains early access to pre-vetted deal flow across Africa, Latin America, and Southeast Asia. Selected companies are eligible to receive $250,000 in capital alongside strategic support, ranging from investor-grade financial modeling and legal structuring to access to Lisk’s global VC network.
This past September, Lisk celebrated its growing community of founders at ETHSafari, Africa’s largest Ethereum conference. For more information, visit www.lisk.com/fund and access Lisk’s media kit here.
About Lisk Lisk is a growth platform designed for Web3 founders in high-growth markets. We provide the tools founders need to build and scale: capital, local programs, key partnerships, and an Ethereum-aligned Layer 2 primed for deployment.
Lisk takes a founder-first approach that’s both committed and hands-on. We collaborate with teams from early concepts through go-to-market, with on-the-ground teams in Africa, Southeast Asia, and Latin America, helping transform regional challenges into real opportunities.
As a founding member of the Optimism Superchain, Lisk is helping shape the industry’s first fully interoperable network, expanding access for builders with minimal fees, intuitive user experiences, and solutions designed to address local challenges.
Since its inception in 2016, Lisk has focused on tangible routes to Web3 adoption, supporting founders who are tackling pressing local issues and developing lasting solutions.
ST. LOUIS, Oct. 2, 2025 — Gershman Investment Corp. provided construction and permanent financing for Mansion House Apartments in St. Louis, MO. Managing Director Chris Will originated a $78 million dollar HUD 221(d)4 loan for this historic 29-story high-rise tower. Adjacent to the Gateway Arch, with 415 apartments units, Mansion House is one of St. Louis’s most iconic riverfront properties. Renovations to the 1960’s-era building will take less than two years to complete, with fully modernized units being delivered in 2027. The $195 million dollar investment represents one of the largest residential investments Downtown St. Louis has seen in decades, and will mark a new chapter in the life of this historic property.
In addition to the HUD-insured debt provided by Gershman, sources of funding include State and Federal Historic Tax Credits, Opportunity Zone capital from Catalyst Opportunity Funds, and gap financing from Arch to Park Equity Fund. Real estate tax-abatement and sales tax exemption on construction materials was provided by The City of St. Louis.
The $78 million GNMA-backed HUD 221(d)4 provided 40-year fixed, non-recourse, construction – permanent debt. Gershman’s GNMA security was acquired by The Builder’s ProLoan Bond Fund, a pension fund whose members include various labor trade unions. The Fund provided a significantly below-market interest rate.
The FHA 221(d)(4) Substantial Rehabilitation loan is a government-insured financing program designed to fund the purchase and major renovation of multifamily rental properties. It provides long-term, fixed-rate, non-recourse financing that covers both construction costs and permanent debt in a single loan.
Gershman Investment Corp. is one of the nation’s few independently owned mortgage companies that offer FHA-insured multifamily and healthcare financing. Our extensive history of 70 years of personal service, expertise, and dedication to problem-solving ensures a smooth process for financing of project loans. We rank among the top ten originators of FHA multifamily programs by the US Department of Housing and Urban Development. We are one of a small, select group of lenders nationwide to be HUD-approved for MAP (Multifamily Accelerated Processing) for apartments and LEAN processing for nursing homes and assisted living facilities. For more information about Gershman Investment Corp., please visit www.gershmaninvestmentcorp.com.
7800 Forsyth Blvd, Suite 700, St. Louis, MO 63105 | (314) 889-0600
Partnership to Accelerate Job Creation and Innovation in AI, Robotics, and Supply Chain as part of two NJEDA Investment programs.
NEW YORK, Oct. 2, 2025 —Interwoven Ventures (Interwoven), an early-stage venture capital firm specializing in robotics and artificial intelligence (AI), has been selected by the New Jersey Economic Development Authority (NJEDA) to co-invest through the New Jersey Innovation Evergreen and Venture Fund Investments Programs. The Partnership will channel capital and expertise into New Jersey startups driving innovation in manufacturing, logistics, healthcare and transportation.
Interwoven Ventures invests and advises founders, startups, universities and centers of innovation on AI’s transformative impact across industries particularly within manufacturing, logistics, transportation, and healthcare. Interwoven brings guidance and expertise in driving operational efficiencies, automation, and innovation—particularly in areas like predictive analytics and AI-powered diagnostics.
“New Jersey is a magnet for bold entrepreneurs, and we’re proud to partner with NJEDA to help founders scale,” said Erez Agmoni, co-founder and General Partner of Interwoven Ventures. “At Interwoven, we don’t just write checks, we bring decades of operational experience, a deep industry network, and hand-on guidance in AI and Robotics. The collaboration gives startups in New Jersey access to both capital and know-how to turn breakthrough ideas into lasting business.”
“Under Governor Murphy’s leadership, the New Jersey Innovation Evergreen Fund has empowered high-potential startups by establishing a self-sustaining investment cycle that attracts capital,” said NJEDA Chief Executive Officer Tim Sullivan. “Through the funding of Qualified Venture Firms such as Interwoven Ventures, this innovative program is fueling the growth of businesses, reinforcing New Jersey’s standing as a premier global hub for innovation.”
Whether you’re a founder building the next breakthrough in AI and Robotics, an investor looking to co-invest in frontier technologies, or an innovation partner shaping the future of New Jersey’s economy, we invite you to connect with Interwoven Ventures at www.interwoven.vc .
About Interwoven Ventures Interwoven Ventures is an early-stage venture capital firm specializing in robotics and AI, with a focus on transformative opportunities in industries like manufacturing, logistics, transportation, and healthcare. Since its inception in 2022 as an incubated venture of ROBO Global, the firm has been committed to leveraging decades of industry and operational expertise to empower visionary entrepreneurs and build a foundation for long-term success and innovation. For more information, please visit interwoven.vc.
About the NJEDA The New Jersey Economic Development Authority (NJEDA) serves as the State’s principal agency for driving economic growth. The NJEDA is committed to making New Jersey a national model for inclusive and sustainable economic development by focusing on key strategies to help build strong and dynamic communities, create good jobs for New Jersey residents, and provide pathways to a stronger and fairer economy. Through partnerships with a diverse range of stakeholders, the NJEDA creates and implements initiatives to enhance the economic vitality and quality of life in the State and strengthen New Jersey’s long-term economic competitiveness.
One of few Reg A+ raises in history to surpass $70M; Pacaso’s total equity funding now tops $300M as demand surges for luxury co-ownership
SAN FRANCISCO, Oct. 2, 2025 — Pacaso, the tech-enabled marketplace for co-owned luxury vacation homes, today announced the close of its record-setting SEC-qualified Regulation A+ growth round, raising over $72.5 million from more than 17,500 individual investors. ¹ Pacaso’s raise is the largest real estate Reg A+ offering of 2025 and one of only a handful of companies in history to surpass $70 million, cementing the company as one of the most significant Reg A+ issuers to date. The milestone brings Pacaso’s total equity funding to more than $300 million and highlights growing demand for access to real estate and early-stage equity opportunities.
“This raise was proof that thousands of people believe in a better, smarter way to own and experience a vacation home,” said Austin Allison, co-founder and CEO of Pacaso. “The overwhelming demand exceeded expectations, showing that co-ownership is more than a trend — it’s a movement. By combining the power of community with institutional support, we’re making luxury ownership more attainable and more meaningful for families and investors around the world.”
Pacaso’s raise was powered by DealMaker, whose capital-raising platform enabled the company to scale its community-first campaign to tens of thousands of prospective investors.
“This deal is a perfect example of how retail investors can be a valuable source of funding for high-growth companies in conjunction with institutional and venture capital,” said Rebecca Kacaba, co-founder and CEO of DealMaker. “We’re proud to have helped Pacaso engage such a broad base of individual investors in this investment round — fueling future growth while giving those investors a unique opportunity to be part of something transformative.”
Pacaso’s record raise builds on several recent milestones:
Institutional validation: Pacaso recently secured a $100 million credit facility with Texas Capital to launch the industry’s first mortgage purpose-built for co-ownership.
Operational strength: The company reported $12.6 million in adjusted gross profit in the first half of 2025, with improving margins and reduced cash burn. ²
Growth trajectory: Pacaso has facilitated more than $1.2 billion in transactions and service fees to date, ³ generated over $138 million in lifetime gross profit, ² and expanded into 40+ destinations across the U.S., Mexico, and Europe, with 10 new international market listings including London, Paris, Italy, and the Caribbean.
Pacaso’s $72.5 million Reg A+ raise is the largest real estate offering of 2025. It is nearly five times the SEC’s historical average of about $12.5 million, 4 and few Reg A+ issuers in any sector cross the $30 million mark. 5
“Pacaso is proud to have led one of the most significant Reg A+ raises in history,” said Tom Mulholland, Head of Strategic Initiatives and Capital Development at Pacaso. “By welcoming thousands of retail investors to join our mission, we’re broadening access to an opportunity once limited only to institutions. This outcome underscores the confidence in our vision and expands the Pacaso community in several powerful ways.”
Founded in 2020 by tech entrepreneurs Austin Allison and Spencer Rascoff, Pacaso is the global co-ownership category leader, enabling buyers to co-own luxury vacation homes in top destinations worldwide. The company offers ownership shares ranging from one-eighth to one-half, paired with flexible financing, professional management, turnkey design, and full-service support that includes scheduling, maintenance, and resale assistance. Pacaso also leverages AI-powered tools to scale operations and enhance the owner experience.
About Pacaso Co-founded by Austin Allison and Spencer Rascoff in 2020, Pacaso® is a technology-enabled marketplace that modernizes real estate co-ownership, enabling families to effortlessly own a luxury vacation home and travel with confidence. Pacaso curates private residences in premier destinations across the U.S. and internationally, with exceptional amenities, luxury interiors and expert design. After purchase, Pacaso professionally manages the home, provides white-glove scheduling and personalized service, and ensures seamless resale.
¹ Investor participation. Based on internal company records as of September 2025.
² We calculate Adjusted Gross Profit as gross profit under GAAP adjusted for amortization of developed technology, inventory valuation adjustment in the current period, inventory valuation adjustment in prior periods, impairments and write-offs and share-based compensation. Inventory valuation adjustment in the current period is calculated by adding back the inventory valuation adjustments recorded during the period on homes that remain in inventory at period end. Inventory valuation adjustment in prior periods is calculated by subtracting the inventory valuation adjustments recorded in prior periods on homes sold in the current period. Additionally, we calculate Adjusted Gross Profit Excluding Impact of Whole Homes, which is an indication of the performance of our core business offering of selling and managing co-owned real estate and is a useful measure of the volume of transactions that flow through our platform in a given period. We view this metric as an important measure of business performance, as it captures gross profit performance related to units transacted in a given period and provides comparability across reporting periods.
3 We define Gross real estate transacted and associated service fees, excluding whole home sales, as the total dollar value, less any concessions, of co-ownership transacted during the period, which includes co-ownership real estate sales, gain from real estate investments presented gross, real estate services, and the applicable margin on such transactions. We view this metric as an indication of the performance of our core business offering of selling co-owned real estate and is a useful measure of the volume of transactions that flow through our platform in a given period, which ultimately impacts gross profit.
4 Historical averages: SEC Division of Economic and Risk Analysis, Regulation A and Regulation Crowdfunding Offerings: 2025 Update, June 2025. The report notes Tier 2 Regulation A issuers raised an average of about $12.5 million from 2015 through 2024 across more than 1,400 offerings.
5 Market comparison. Based on external industry research and publicly available issuer filings. The SEC does not publish average raise sizes by vertical; this comparison reflects aggregated data on real estate-focused Reg A+ campaigns.
Certain statements in this release may constitute “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements include, but are not limited to, statements regarding Pacaso’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Readers are cautioned not to put undue reliance on forward-looking statements, and Pacaso assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Pacaso does not give any assurance that it will achieve its expectations.
In addition to financial results presented in accordance with generally accepted accounting principles, this press release may contain financial measures that do not conform to U.S. GAAP if we believe they are useful to investors or if we believe they will help investors to better understand our performance or business trends. Reconciliations of these non-GAAP financial measures to the nearest comparable GAAP measures are included in our Offering Statement, which may be obtained from: invest.pacaso.com.
AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AVAILABLE HERE.
Following $40M Series B, CertifyOS launches Provider Hub to unify provider data into a single source of truth for health plans and digital health companies
NEW YORK, Oct. 2, 2025 — CertifyOS, the provider data intelligence company, today announced the launch of Provider Hub, its Provider Data Management (PDM) solution—the only end-to-end platform offering a unified, real-time, 360-degree view of every provider in a healthcare organization’s network.
Inaccurate provider data creates friction across nearly every function of a health plan. It harms member experience, delays payments, and increases compliance risk under mandates like the No Surprises Act and the Transparency in Coverage Rule. Despite its central role in operations, provider data has long been managed through siloed systems, spreadsheets, and outdated tools that can’t keep up with today’s demands.
“Unlike calcified legacy systems or traditional PDM solutions that don’t integrate with other systems, require costly IT resources, and take months or years to implement, CertifyOS takes a fundamentally different approach,” said Anshul Rathi, founder and CEO of CertifyOS. “We don’t digitize old workflows—we replace them. Because we are a data company at heart, we enable organizations to go from storing data to unlocking its enterprise-wide potential. This is the infrastructure healthcare needs, and the future we’ve been building toward since day one.”
CertifyOS’s Provider Hub ingests, cleanses, normalizes, and validates data from a wide range of sources—including credentialing, directories, claims, rosters, and internal systems—to power critical workflows that sit on top of this data and deliver operational insights across an enterprise. This reduces manual effort and leads to fewer silos, fewer vendors, fewer delays, and lower costs. The company already has multiple signed deals with customers seeking to address persistent pain points like credentialing delays, data duplication, and compliance risk.
An AI-Powered, Transparent, and Flexible Provider Data Backbone
As a continuously updated source of truth, CertifyOS’s solution enables organizations to improve data accuracy, drive system-wide intelligence, and reliably scale automation and AI. According to Gartner, 85% of AI projects fail—often due to poor data quality. CertifyOS’s platform provides the trusted foundation needed.
The solution is built to meet health plans where they are today and help transform operations for the future. It can:
Ingest and unify provider data from structured and unstructured sources into a single, complete profile.
Clean, standardize, and validate data using thousands of rules and 1,600+ primary sources.
Resolve duplicates and link records across systems using AI-driven logic to maintain data integrity.
Set and apply custom rules to prioritize the most authoritative or recent data when conflicts arise.
Model complex relationships between providers, groups, locations, and plans, with full audit trails.
Integrate directly with downstream systems including credentialing, contracting, directories, and claims.
Activate insights across departments to identify gaps, flag issues, and support decision-making.
Run credentialing, monitoring, and outreach workflows in real time to reduce turnaround and touchpoints.
Continuously monitor provider data and deliver alerts on expirations, sanctions, or outdated records.
“Every function inside a health plan touches provider data, yet most still operate on outdated tools that weren’t designed for today’s complexity,” added Rathi. “What makes this platform different is its ability to serve as a single foundation across departments. It enables better performance across claims, compliance, directories, and provider experience—not by patching existing systems, but by fixing the root issue. When provider data is reliable, everything downstream runs better. That’s the transformation this platform enables.”
About CertifyOS CertifyOS is the architect of modern provider data infrastructure — combining best-in-class technology, best-in-class data, and deep domain expertise to transform how healthcare operates. Entering the market in 2021 as a credentialing platform, CertifyOS now powers the full provider data lifecycle through a continuously updated source of truth powered by thousands of primary sources and available through one API. The provider data intelligence company is backed by esteemed investors including Transformation Capital, General Catalyst, Upfront Ventures, and SemperVirens. For more information, please visit us at CertifyOSos.com.
GÖTTINGEN, Germany, Oct. 2, 2025 — German biotech company Repairon GmbH announced the completion of a Series A round of financing that will enable further clinical development of its groundbreaking regenerative heart failure therapy. The therapy repairs cardiac function and holds the potential to significantly improve quality of life in patients with advanced heart failure by engrafting lab-engineered cardiac cell sheets to the surface of a damaged ventricle. This approach is currently being tested in a Phase 1/2 clinical study in Germany. Recruitment for the interim analysis of the Phase 2 was completed recently. Preclinical outcomes were published in the journal Nature earlier this year.
Led by Bioventure Management GmbH and strategic co-investor Satorius AG, the financing will enable the transition to a European Phase 3 registration trial and the scaling of GMP (Good Manufacturing Practice) production in collaboration and with know-how from Satorius AG. Erik Hoppe, Ph.D., Managing Director of Bioventure, said: “Repairon stands for visionary research with social relevance. The company has the potential to fundamentally change the treatment of heart failure.” Lothar Germeroth, Ph.D., CEO of Repairon, added that “the engineered heart muscle offers the prospect of reversing the course of congestive heart failure and significantly improving quality of life. For the first time, we see the opportunity to treat a previously incurable and expensive disease causally – with real global benefits for both patients and healthcare systems.”
The approach to repair damaged heart muscle with lab-produced heart tissue sheets is based on more than 30 years of research led by Wolfram-Hubertus Zimmermann, MD, Ph.D., professor and director of the Institute of Pharmacology and Toxicology at the University Medical Center Goettingen (UMG) in Northern Germany. Repairon, UMG, and the German Center of Cardiovascular Research (DZHK) collaborate closely on the development of this technology.
High medical need in advanced heart failure: Approximately 5% of the population in Germany suffers from chronic heart failure of any severity, and it is the third most common cause of death in this country. In the US, heart failure represents the most common cause of hospitalization and mortality in the senior population, and over 6 million people are affected. As the heart failure progresses to advanced stages, patients experience weakness with discomfort during all physical activities and at rest, sometimes even requiring constant bed rest. For these severely ill patients, the only treatment options currently available are mechanical pump devices or heart transplantation.
About Repairon: Repairon GmbH is a German biotech company based in Göttingen, Germany, focused on developing regenerative cell therapies for cardiac medicine. The company was founded in 2014 based on research by Wolfram-Hubertus Zimmermann, MD, Ph.D. and his team at the University Medical Center Goettingen, who have developed several tissue engineering technologies with proven applicability for organ repair and drug development. Repairon’s lead therapeutic candidate, the human engineered heart muscle sheet, is currently being evaluated in the BioVAT-HF Phase 2 clinical trial as a biological ventricular support tissue for end-stage heart failure.
About Bioventure: Founded in 2001, Bioventure has evolved from a specialized consulting firm into a successful investor in life science companies. Its focus is on companies with the potential to achieve measurable improvements in healthcare through biomedical innovations. Its investment model is based on exclusive financing vehicles (club deals), allowing wealthy entrepreneurial families and family offices to participate in promising individual projects. Bioventure’s active support – from selection and strategic development to exit – has led to the distribution of more than €100 million to investors. Successful exits with company valuations in the hundreds of millions to billions of euros underscore Bioventure’s expertise in scaling high-growth startups.
